Published in Strahlenther Onkol on April 05, 2013
Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol (2015) 0.80
Mesonephric adenocarcinoma of the vagina : Diagnosis and multimodal treatment of a rare tumor and analysis of worldwide experience. Strahlenther Onkol (2016) 0.75
[Grading of gynecological tumors : Current aspects]. Pathologe (2016) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe (1987) 7.27
Cancer statistics, 1997. CA Cancer J Clin (1997) 5.22
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol (1994) 2.10
Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry (1993) 1.77
The National Cancer Data Base report on cancer of the vagina. Cancer (1998) 1.69
Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol (2007) 1.50
p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol (1996) 1.40
Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys (2005) 1.16
Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer (2008) 1.12
Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys (1996) 1.08
Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys (1999) 1.02
Advances in vulvar and vaginal cancer treatment. Gynecol Oncol (2010) 0.99
Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol (2009) 0.99
A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol (1995) 0.98
High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. Int J Radiat Oncol Biol Phys (2003) 0.97
Carcinoma of the vagina. Factors influencing treatment outcome. Cancer (1985) 0.94
Long-term results of radiotherapy in primary carcinoma of the vagina. Strahlenther Onkol (2009) 0.90
Carcinoma of the vagina--experience at the Princess Margaret Hospital (1974-1989). Gynecol Oncol (1995) 0.90
Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Gynecol Oncol (2007) 0.86
Concurrent chemoradiation for locally advanced squamous cell carcinoma of the vagina: case series and literature review. Int J Clin Oncol (2008) 0.85
The curative potential of radiation therapy in the treatment of primary vaginal carcinoma. Am J Clin Oncol (1996) 0.85
Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer (2006) 0.84
The role of interstitial brachytherapy in the treatment of vaginal and vulvar malignancies. Strahlenther Onkol (2006) 0.84
Twenty-year review of radiotherapy for vaginal cancer: an institutional experience. Gynecol Oncol (2008) 0.84
Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy. Cancer (2001) 0.81
Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT: Part 2. Strahlenther Onkol (2011) 0.81
Radiotherapy for vaginal carcinoma: a 23-year review. Br J Radiol (2000) 0.81
Indiana University experience in the management of vaginal cancer. Int J Gynecol Cancer (2009) 0.80
The importance of brachytherapy technique in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys (1992) 0.80
Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys (2000) 0.79
Radical radiation therapy for carcinoma of the vagina--impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970-1990. Int J Radiat Oncol Biol Phys (1993) 0.79
Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol (1991) 0.79
Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor. Cancer (1996) 0.78
Squamous cell carcinoma of the vagina: a review of 70 cases. Gynecol Oncol (1993) 0.77
Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol (1996) 0.76
[Results of radiotherapy for primary vaginal cancer]. Strahlenther Onkol (1997) 0.75
[Radiotherapy of primary vaginal carcinoma and effects of histological and clinical factors on the prognosis]. Strahlenther Onkol (1991) 0.75
Primary invasive squamous cell carcinoma of the vagina. Acta Obstet Gynecol Scand (1989) 0.75
Radiation therapy for primary squamous cell carcinoma of the vagina: Stanford University experience. Gynecol Oncol (1989) 0.75
[Vaginal cancer: primary invasive squamous cell carcinoma in adults]. Bull Cancer (1989) 0.75
Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failures analysis--the M. D. Anderson Hospital experience 1955-1982. Int J Radiat Oncol Biol Phys (1988) 0.75
Squamous cell carcinoma of the vagina: a report of 32 cases. Int J Gynecol Cancer (1994) 0.75
Radiotherapy of primary carcinoma of the vagina: management and results of different therapy schemes. Gynecol Oncol (1985) 0.75
[Effect of brachytherapy and teletherapy on treatment results in primary vaginal cancer]. Strahlentherapie (1984) 0.75
Results of radiotherapeutic management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys (1991) 0.75
Radiation therapy of primary vaginal carcinoma. Int J Radiat Oncol Biol Phys (1983) 0.75
Carcinoma of the vagina. J Epidemiol Biostat (2001) 0.75
Management of radiation injuries of vulva and vagina. Strahlenther Onkol (1998) 0.75
Therapeutic and prognostic considerations in primary carcinoma of the vagina. Acta Obstet Gynecol Scand (1995) 0.75
The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer (1996) 3.05
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat (2014) 1.35
BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat (2006) 1.33
Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer. Eur J Cancer Care (Engl) (2013) 0.90
Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast Cancer Res Treat (2001) 0.88
Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study. J Surg Oncol (1999) 0.87
Vaginal and pelvic recurrences in stage I and II endometrial carcinoma--survival and prognostic factors. Eur J Gynaecol Oncol (2011) 0.86
Male breast cancer. Does the prognosis differ compared to female? Neoplasma (2000) 0.85
The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx. Auris Nasus Larynx (1998) 0.81
The efficiency of treatment in patients with uterine-confined endometrial cancer. Eur J Gynaecol Oncol (2006) 0.79
Parachordoma: a rare sarcoma with clonal chromosomal changes. Cancer Genet Cytogenet (1998) 0.79
Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure. Strahlenther Onkol (2013) 0.79
Radical external beam radiotherapy of urinary bladder carcinoma. An analysis of results in 500 patients. Acta Oncol (1994) 0.78
Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy. Radiother Oncol (1999) 0.78
Defining the histopathological changes induced by nonablative radiofrequency treatment of faecal incontinence--a blinded assessment in an animal model. Colorectal Dis (2015) 0.78
The efficiency and tolerance of half-body irradiation (HBI) in patients with multiple metastases. The Krakow experience. Strahlenther Onkol (2001) 0.77
Multimodality treatment of noninflammatory stage IIIb breast cancer. J Surg Oncol (1997) 0.77
[Results of a randomized prospective trial comparing postoperative abdominopelvic radiotherapy with postoperative chemotherapy in early ovarian cancer]. Cancer Radiother (2001) 0.77
Ultrastructure of diffuse malignant mesothelioma of the pleura. An analysis of ten cases. Patol Pol (1993) 0.77
Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinoma. Cancer (1993) 0.77
Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Oncology (1993) 0.77
Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer. Eur J Gynaecol Oncol (2014) 0.77
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. World J Surg (2016) 0.77
Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol (1996) 0.76
Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2. Pol J Pathol (2014) 0.76
The reirradiation of recurrences of head and neck cancer. Br J Radiol (1980) 0.76
Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas. Diagn Mol Pathol (1996) 0.76
[Follow-up of 70 patients with advanced ovarian cancer after negative second-look laparotomy]. J Gynecol Obstet Biol Reprod (Paris) (2006) 0.76
Expression of multidrug-resistance-associated protein gene in human soft-tissue sarcomas. J Cancer Res Clin Oncol (1996) 0.75
Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality. Genes Chromosomes Cancer (2001) 0.75
[Clinico-morphological evaluation of primary non-epithelial breast neoplasms]. Patol Pol (1989) 0.75
Flow cytometric DNA-analysis of cells obtained with fine needle aspiration biopsy of the breast. Gen Diagn Pathol (1996) 0.75
[Use of electrons in radiotherapy. 11-year experience of the Cracow Branch of the Center of Oncology]. Nowotwory (1990) 0.75
An outline of the history of radiation oncology in Poland. Int J Radiat Oncol Biol Phys (1996) 0.75
Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study. Pol J Pathol (1999) 0.75
DNA analysis of laryngeal carcinoma cells by flow cytometry: the histoclinical factors and their significance. J Otolaryngol (2000) 0.75
[Role of radiotherapy in the treatment of patients with non-small-cell lung cancer]. Nowotwory (1990) 0.75
[Enzinger's clear cell sarcoma. Case report]. Patol Pol (1987) 0.75
[Extramedullary plasmocytoma of the larynx. Analysis of four cases]. Otolaryngol Pol (1998) 0.75
[Synchronous bilateral carcinoma of the lung cured with surgery and radiotherapy]. Pneumonol Alergol Pol (1997) 0.75
[Exclusive radiotherapy in 250 cases of stage I-II cancers of the supraglottic larynx]. Bull Cancer Radiother (1996) 0.75
[Kaposi's sarcoma. Clinical picture, treatment and prognosis. II. Evaluation of the stage of growth, treatment and prognosis]. Nowotwory (1988) 0.75
[Cervix neoplasms in women younger than 36 years of age]. Ginekol Pol (1996) 0.75
Evaluation of DNA content and proliferative activity in prediction of short-term relapses in mammary carcinoma: a prospective study. Pol J Pathol (1999) 0.75
[Results of radioisotope teletherapy of cancer of the larynx]. Nowotwory (1989) 0.75
Flow cytometric evaluation of Ki67 proliferative antigen in primary breast cancer. Pol J Pathol (1995) 0.75
[Infiltrating lobular carcinoma of the breast. Clinical picture, treatment and prognosis]. Ginekol Pol (1998) 0.75
Progesterone but not estradiol 17beta potentiates local GH secretions by hormone-dependent breast cancer explants. An in vitro study. Exp Clin Endocrinol Diabetes (2005) 0.75
[Effect of thymectomy on the morphology of adrenals in rat]. Endokrynol Pol (1972) 0.75
Haemangioendothelioma epithelioides. Case report of a rare soft tissue tumour. Patol Pol (1991) 0.75
[Irradiation of patients with ovarian cancer applying the moving strip technique. Preliminary estimation of tolerance and efficacy]. Nowotwory (1989) 0.75
[Morphologic and clinical evaluation of malignant non-epithelial and mixed neoplasms of the genital organs. I. Heterologous sarcoma, stromal sarcoma, carcinosarcoma and adenocarcinoma]. Patol Pol (1987) 0.75
[Breast cancer in women under the age of 35]. Ginekol Pol (1994) 0.75
[Half body-irradiation performed at the Cracow branch of the Oncology Center]. Nowotwory (1988) 0.75
[The role of teleradiotherapy in treatment of thyroid cancer]. Wiad Lek (2001) 0.75
[Small cell laryngeal cancer: analysis of literature and a report of two cases]. Otolaryngol Pol (1994) 0.75
Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis. Pol J Pathol (1994) 0.75
Relationship of histology, DNA-values and proliferative activity in unselected breast cancer patients (a preliminary study). Pol J Pathol (1995) 0.75
[Morphological and clinical evaluation of non-epithelial and mixed neoplasms of the female reproductive organs. II. Leiomyosarcoma]. Patol Pol (1990) 0.75
[Primary fallopian tube carcinoma. Analysis of 32 cases]. Ginekol Pol (1996) 0.75
Clinical picture of infiltrating lobular carcinoma of the breast: an analysis of 96 patients. Eur J Gynaecol Oncol (2013) 0.75
Prognostic assessment of histologic parameters in breast carcinomas: a prospective study. Gen Diagn Pathol (1998) 0.75
[The role of radiotherapy in the treatment of patients with small cell carcinoma of the lungs]. Nowotwory (1989) 0.75
[Prognostic factors in patients with ovarian cancer]. Ginekol Pol (1992) 0.75
[Evaluation of the effectiveness of palliative irradiation with high fractionated doses and planned intervals in patients with advanced cancer of the oral cavity and pharynx]. Nowotwory (1989) 0.75
[Teratoma of the ovary. Analysis of prognostic factors]. Ginekol Pol (1995) 0.75
[Radiation therapy in glottic laryngeal carcinoma stage. I. Results and analysis of prognostic factors]. Otolaryngol Pol (1996) 0.75
Flow cytometric analysis of high grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis. Pol J Pathol (1994) 0.75
Pure immature teratoma of the ovary: analysis of 22 cases. Eur J Gynaecol Oncol (1997) 0.75
[Primary non-epithelial malignant lung neoplasms]. Patol Pol (1987) 0.75
Assessment of proliferative activity, DNA values and some clinicopathologic parameters in mesenchymal tumors. Immunohistochemical and flow cytometric study. Gen Diagn Pathol (1997) 0.75
Flow cytometric analysis of immunophenotypic and DNA values in non-Hodgkin's B-cell lymphomas classified according to the Kiel Classification and Working Formulation. Pol J Pathol (1994) 0.75
[Angioimmunoblastic lymphadenopathy--clinical and morphologic evaluation of 6 cases]. Patol Pol (1987) 0.75
Comparative flow cytometric DNA analysis on fresh and paraffin-embedded tumor tissue in different neoplasms. Pol J Pathol (1994) 0.75
Alveolar soft part sarcoma: an analysis of 8 cases. Review of the literature. Patol Pol (1991) 0.75
Rhabdomyosarcoma. Morphologic, immunohistochemical, and DNA study. Gen Diagn Pathol (1997) 0.75
[The prognostic significance of impaired vocal cord motility in patients with stage II glottic cancer treated with radiotherapy]. Otolaryngol Pol (1997) 0.75
[Adenoid cystic carcinoma of the breast. Analysis of 7 patients]. Ginekol Pol (1998) 0.75
Mesenchymoma malignum of the buttock. Pathol Res Pract (1989) 0.75
[Recurrent disseminated intravascular coagulation in the course of gastrointestinal stromal tumor (GIST)]. Pol Arch Med Wewn (2001) 0.75
Nuclear morphometry for the prediction of regional lymph nodes metastases in patients with cancer of the larynx. Otolaryngol Head Neck Surg (2000) 0.75
Adult Wilms' tumor. Eur J Cancer (1991) 0.75
[Homogeneous dysgerminoma of the ovary. Analysis of 25 cases]. Ginekol Pol (1995) 0.75
[Is gender a prognostic factor in early stages of laryngeal cancer treated by radiotherapy?]. Otolaryngol Pol (1997) 0.75
[Lymphomatoid papulosis (Macaulay's disease). Description of 3 cases]. Patol Pol (1988) 0.75
[20-year survival in women with breast cancer]. Przegl Lek (1997) 0.75
Whole abdominal external beam radiation in the treatment of primary carcinoma of the fallopian tube. Gynecol Oncol (1997) 0.75
[Morphometric analysis of cell nuclei and regional lymph node status with patients suffering from laryngeal carcinoma]. Otolaryngol Pol (2000) 0.75
[Primary malignant lymphoma of the thyroid gland--diagnosis and treatment tactics]. Przegl Lek (1997) 0.75